“Ground State” Adult Stem Cells in Regenerative Medicine, Disease

Comments

Transcription

“Ground State” Adult Stem Cells in Regenerative Medicine, Disease
Department of Microbiology & Immunology Programme
Seminar Series … May 2015
Day / Date / Time
th
Monday 4 May 2015
1pm
“Ground State” Adult Stem Cells in Regenerative
Medicine, Disease Modeling, and Cancer
Therapeutics Discovery
Profs dfad f
Venue
Professor Frank McKeon
National University of
Singapore (NUS),
Department of
Microbiology,
Seminar Room @
5 Science Drive 2,
Blk MD4A, Level 2,
Singapore 117545
Genome Institute of Singapore
MultiClonal Therapeutics, Inc.
Convener
Prof Nicholas Gascoigne
ALL ARE
WELCOME
Abstract
Induced pluripotent stem cells (iPSCs) dominate prospective efforts in regenerative
medicine and disease modeling despite organic features that limit their utility. In contrast,
resident adult stem cells, especially those of regenerative columnar epithelia such as the
gastrointestinal tract, liver, pancreas, and kidney, have been largely ignored because of
technical barriers that prevent their cloning and propagation. The lab has now developed
robust methods for cloning the adult stem cells from these tissues in their most immature,
ground state. This technology is beginning to unravel basic properties of the adult stem
cells including their unlimited expansion ability and epigenetic memory of both lineage
commitment and in some cases chronic disease states. Moreover, ground state stem cells
show a remarkable ability to assemble complex structures similar to mature tissues
without external guidance. These properties, combined with the ease of generating stem
cells from endoscopic biopsies, suggest that patient-specific, ground state stem cells
represent a viable alternative to iPSCs in regenerative medicine and disease modeling. In
addition to ground state stem cells of regenerative epithelia, this technology has been
applied to stem cells of highly aggressive epithelial cancers such as those of the
esophagus, stomach, pancreas, liver, and ovary. From “libraries” of such cancer stem
cells from individual cases the immense heterogeneity of these tumors can be
reconstructed from a genomics analysis of the individual constituent clones. From the
therapeutic standpoint, these libraries enable the discovery of intrinsically (pre-therapy)
resistant clones that most likely mount recurrent disease following standard-of-care
chemotherapy. Such approaches have tremendous potential for tailoring cancer therapies
to each patient.
About our speaker
Visit our website @
www.med.nus.edu.sg/mbio
for more upcoming
seminars
Frank McKEON and Wa XIAN jointly oversee a highly interactive group devoted to the
cloning of stem cells of regenerative tissues and using advanced technologies to understand
the genetics of their self-renewal, commitment, and differentiation. They have a strong
interest in determining pathways by which these stem cells might contribute to regenerative
medicine especially for lung and liver, and pancreatic diseases. In addition, they have a strong
interest in precursors of cancers- in particular early lesions that lead to high-grade ovarian
cancers as well as in the origins of intestinal metaplasias which precede esophageal, gastric,
and pancreatic adenocarcinoma. Frank McKeon was born in New Haven, Connecticut, and
was an undergraduate at Pomona College. He did his doctoral and postdoctoral studies in
Biochemistry and Biophysics with Prof. Marc Kirschner at the University of California, San
Francisco. He worked at Harvard University for more than twenty years and joined the
Genome Institute of Singapore as a Senior Group leader in 2008. He spent three years at
Jackson Laboratory for Genomic Medicine as director of Quantitative Cell Biology before his
present position shared between MultiClonal Therapeutics and the Genome Institute of
Singapore. He has worked in several areas of cell biology including nuclear lamin dynamics,
the spindle assembly checkpoint monitoring chromosome segregation, the role of NF-AT
transcription factors in T cell activation, and mouse models of the p53 homologs p63 and p73.

Similar documents

Market Overview – Regenerative Medicine Market Shares, Strategies And Forecasts to 2023: Credence Research

Market Overview – Regenerative Medicine Market Shares, Strategies And Forecasts to 2023: Credence Research Credence Research has recently issued a new market assessment report titled “Regenerative Medicine – Growth, Future Prospects and Competitive Analysis, 2016 – 2022”. The global Regenerative Medicine Market study provides a comprehensive view of the ongoing and future phases of the Regenerative Medicine industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution. Browse the report at http://www.credenceresearch.com/report/regenerative-medicine-market Based on geographic/regional distribution the global Regenerative Medicine Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Regenerative Medicine Market based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa markets. Among these, the North America, Europe and Asia-Pacific Regenerative Medicine Market is studied for top country-level markets. The Regenerative Medicine industry in each individual country market is studied based on parameters such as per capita income, population, gross domestic product (GDP), status of infrastructure, purchasing power parity, etc. Technology development, industry concentration, end-user preference, and similar such grounds are also considered while estimating the market for Regenerative Medicine. The market estimates are provided for the period 2014-2022, along with corresponding compounded annual growth rates (CAGRs) for the forecast period 2016-2022. Request Table of content - http://www.credenceresearch.com/request-table-of-content/58213 This report on Regenerative Medicine Market also offers competition assessment tools such as market positioning of key players, attractive investment proposition, and Porter’s Five Forces model to give the readers a view of the competitive scenario of the Regenerative Medicine Market. The Regenerative Medicine Market report is concluded with company profiles chapter. This section highlights major information about the key players engaged in development, manufacture, distribution and sale of Regenerative Medicine in the international markets. Request free sample - http://www.credenceresearch.com/sample-request/58213 Major extracts from the Table of Content of Regenerative Medicine Market, 2016-2022 report: Regenerative Medicine Market Dynamics – Drivers, Challenges, Opportunities Regenerative Medicine Market Size and Forecast for the Period 2014-2022 Regenerative Medicine Market CAGR for the Period 2016-2022 Regenerative Medicine Market Competitive Analysis, by Key Players Regenerative Medicine Market: Attractive Investment Proposition, by Geography Regenerative Medicine Market: Key Commercial Events Regenerative Medicine Market: Future Prospects (upcoming product approvals) About Us: Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task. Who we are Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals. Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa. Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect. What we do We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability. No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies. Media Contact Name: Chris Smith (Global Sales Manager) Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US E-mail: [email protected] Ph: 1-800-361-8290 Web: http://www.credenceresearch.com

More information

Global Regenerative Medicine Market

Global Regenerative Medicine Market Regenerative medicine is a category of research in tissue engineering and molecular biology which deals with the method for human cells, tissues and organs reco nstruction to reactivate normal body function. The regenerative medicine repairs the defective cells and tissues. Regenerative medicine treats the basic cause of disease, injuries and genetic conditions. Regenerative medicine gives complete treatment of the abnormality or disease as compared to the symptomatic treatments. Regenerative medicine is a treatment technique which works in three approaches which ensure the complete eradication of the injury of the cell, tissue or organ. There are stem cells and non-stem cell (somatic) therapies which includes taking cells from healthy body organ in the body and applying these cells to the damaged area after expanding these cells in cell culture.

More information